Miloš Arsenijević

Dr. Miloš Arsenijević

University of Kragujevac, Faculty of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Ivan LorencinIvan Lorencin
Ivan Lorencin
Sandi Baressi ŠegotaSandi Baressi Šegota
Sandi Baressi Šegota
Nikola AnđelićNikola Anđelić
Nikola Anđelić
ABAnđela Blagojević
Anđela Blagojević
STSustersic Tijana
Sustersic Tijana
Zlatan CarZlatan Car
Zlatan Car
COVID-19 represents one of the greatest challenges in modern history. Its impact is most noticeable in the health care system, mostly due to the accelerated and increased influx of patients with a more severe clinical picture. These facts are increasing the pressure on health systems. For this reason, the aim is to automate the process of diagnosis and treatment. The research presented in this article conducted an examination of the possibility of classifying the clinical picture of a patient using X-ray images and convolutional neural networks. The research was conducted on the dataset of 185 images that consists of four classes. Due to a lower amount of images, a data augmentation procedure was performed. In order to define the CNN architecture with highest classification performances, multiple CNNs were designed. Results show that the best classification performances can be achieved if ResNet152 is used. This CNN has achieved AUCmacro¯ and AUCmicro¯ up to 0.94, suggesting the possibility of applying CNN to the classification of the clinical picture of COVID-19 patients using an X-ray image of the lungs. When higher layers are frozen during the training procedure, higher AUCmacro¯ and AUCmicro¯ values are achieved. If ResNet152 is utilized, AUCmacro¯ and AUCmicro¯ values up to 0.96 are achieved if all layers except the last 12 are frozen during the training procedure.

18 April 2017 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
MAMiloš Arsenijević
Miloš Arsenijević
MMMarija Milovanovic
Marija Milovanovic
Snežana . Jovanović StevićSnežana . Jovanović Stević
Snežana . Jovanović Stević
NANatalija Arsenijevic
Natalija Arsenijevic
BMBojana Simovic Markovic
Bojana Simovic Markovic
VVVladislav Volarevic
Vladislav Volarevic

30 July 2018 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
MAMiloš Arsenijević
Miloš Arsenijević
SMSlobodan Milisavljevic
Slobodan Milisavljevic
SMStanko Mrvic
Stanko Mrvic
DSDragan Stojkovic
Dragan Stojkovic
Pleural empyema, defined as the presence of purulent material within the pleural space, is the consequence of a suppurative process involving the serous pleural layers. Thoracic empyema is a dynamic process, inflammatory in origin and taking place within a preformed space bordered by both the visceral and parietal pleura. It is a complex clinical entity, neither a sole clinical, laboratory, nor a radiological diagnosis. The primary therapeutic aim: ‘ubi pus evacua’ — if you find pus remove it—has not changed since the age of Celsus. Therefore, treatment of the acute empyema of the pleura is directed to early and complete evacuation of empirical fluid and content, achieving full re-expansion of the lungs and eradication of the infection using appropriate surgical procedures, antibiotics and other supportive procedures. The optimum method of treating empyema should be adjusted to the condition of the patient and the stage of the disease in which the patient is located. The method of treatment depends on the etiology (pneumonic or traumatic), the general condition of the patient and the stage of disease development. By reviewing the available literature, it can be concluded that treating the pleural empyemas is a demanding procedure, in which it is necessary for the treating physician to apply all of his knowledge, and that there is good cooperation with the patient.